Wang N, Jiang K, Huang J, Hou M, Wang L, Wang W
Front Pediatr. 2025; 13:1430803.
PMID: 40013117
PMC: 11861580.
DOI: 10.3389/fped.2025.1430803.
Morado F, Nanda N
Antibiotics (Basel). 2025; 14(1).
PMID: 39858303
PMC: 11762378.
DOI: 10.3390/antibiotics14010017.
Ahmed F, Zhang D, Tang X, Malakar P
Foods. 2025; 13(24.
PMID: 39766969
PMC: 11728422.
DOI: 10.3390/foods13244026.
Kim D, Lee S, Lee J, Whon T, Lee J, Jeon C
Gut Microbes. 2024; 16(1):2412376.
PMID: 39377231
PMC: 11469438.
DOI: 10.1080/19490976.2024.2412376.
Ma Z, Zuo T, Frey N, Rangrez A
Signal Transduct Target Ther. 2024; 9(1):237.
PMID: 39307902
PMC: 11418828.
DOI: 10.1038/s41392-024-01946-6.
Dual-directional regulation of spinal cord injury and the gut microbiota.
Cui Y, Liu J, Lei X, Liu S, Chen H, Wei Z
Neural Regen Res. 2023; 19(3):548-556.
PMID: 37721283
PMC: 10581592.
DOI: 10.4103/1673-5374.380881.
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition.
Larsen I, Chenaux M, Collins F, Mandic A, Hansen L, Lauridsen C
Sci Rep. 2023; 13(1):14941.
PMID: 37696924
PMC: 10495459.
DOI: 10.1038/s41598-023-42128-8.
Isolation and Cultivation of Human Gut Microorganisms: A Review.
Wan X, Yang Q, Wang X, Bai Y, Liu Z
Microorganisms. 2023; 11(4).
PMID: 37110502
PMC: 10141110.
DOI: 10.3390/microorganisms11041080.
Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID-19: A systematic review and meta-analysis.
Zhu J, Pitre T, Ching C, Zeraatkar D, Gruchy S
PLoS One. 2023; 18(3):e0278356.
PMID: 37000812
PMC: 10065254.
DOI: 10.1371/journal.pone.0278356.
Change in the Gut Microbiome and Immunity by Lacticaseibacillus rhamnosus Probio-M9.
Zhang M, Zheng Y, Sun Z, Cao C, Zhao W, Liu Y
Microbiol Spectr. 2023; :e0360922.
PMID: 36912650
PMC: 10100958.
DOI: 10.1128/spectrum.03609-22.
Research progress on the relationship between intestinal microecology and intestinal bowel disease.
Fu Q, Song T, Ma X, Cui J
Animal Model Exp Med. 2022; 5(4):297-310.
PMID: 35962562
PMC: 9434592.
DOI: 10.1002/ame2.12262.
Antagonistic activity of selenium-enriched Bifidobacterium breve against Clostridioides difficile.
Rui W, Gu C, Zhang H, Liao X, Zhao X, Xu Y
Appl Microbiol Biotechnol. 2022; 106(18):6181-6194.
PMID: 35962282
DOI: 10.1007/s00253-022-12124-5.
Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
Lin C, Cheng H, Kuo C, Lee Y, Sung C, Keidan M
Microbiol Spectr. 2022; 10(4):e0048622.
PMID: 35863023
PMC: 9430933.
DOI: 10.1128/spectrum.00486-22.
The Challenges of Eradicating Pediatric Infection in the Era of Probiotics.
Melit L, Marginean C, Sasaran M
Children (Basel). 2022; 9(6).
PMID: 35740732
PMC: 9222169.
DOI: 10.3390/children9060795.
Activation of a passive, mesoporous silica nanoparticle layer through attachment of bacterially-derived carbon-quantum-dots for protection and functional enhancement of probiotics.
Wei H, Geng W, Yang X, Kuipers J, van der Mei H, Busscher H
Mater Today Bio. 2022; 15:100293.
PMID: 35634173
PMC: 9130534.
DOI: 10.1016/j.mtbio.2022.100293.
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
Yang J, Meng L, Yang H
Microbiol Spectr. 2022; 10(2):e0067222.
PMID: 35311540
PMC: 9045379.
DOI: 10.1128/spectrum.00672-22.
Altered Ecology of the Respiratory Tract Microbiome and Nosocomial Pneumonia.
Perez-Cobas A, Baquero F, de Pablo R, Soriano M, Coque T
Front Microbiol. 2022; 12:709421.
PMID: 35222291
PMC: 8866767.
DOI: 10.3389/fmicb.2021.709421.
Probiotics: Potential Novel Therapeutics Against Fungal Infections.
Wu Y, Hu S, Wu C, Gu F, Yang Y
Front Cell Infect Microbiol. 2022; 11:793419.
PMID: 35127557
PMC: 8813855.
DOI: 10.3389/fcimb.2021.793419.
Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice.
Yang J, Yang H
Appl Microbiol Biotechnol. 2021; 105(24):9243-9260.
PMID: 34751791
DOI: 10.1007/s00253-021-11668-2.
The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review.
Zheng Y, Bek M, Prince N, Peralta Marzal L, Garssen J, Pardo P
Front Neurosci. 2021; 15:738220.
PMID: 34744609
PMC: 8568365.
DOI: 10.3389/fnins.2021.738220.